Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

At-Home Sexually Transmitted Infection (STI) Testing Market Revenue Growth Supported By A CAGR Of 3.55% Through 2030

The size of the at-home sexually transmitted infection (STI) testing market has seen rapid expansion over recent years. It is projected to grow from $1.93 billion in 2025 to $2.17 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 12.8%. The growth observed in the past can be attributed to factors such as the increasing global prevalence of sexually transmitted infections, enhanced awareness regarding timely STI diagnosis and treatment, the growing adoption of online healthcare and telemedicine services, expanding public health initiatives focused on HIV and STI screening, and a heightened consumer preference for confidential home healthcare solutions.

The at-home sexually transmitted infection (STI) testing market is projected to experience substantial expansion in the coming years, with its value expected to reach $3.55 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 13.0%. This growth during the forecast period is primarily attributed to factors such as the increasing integration of AI-enabled digital sexual health platforms, a heightened demand for versatile and quick at-home STI diagnostic kits, the expanding use of connected and app-driven testing ecosystems, broader access to direct-to-consumer (D2C) healthcare distribution networks, and an enhanced emphasis on proactive sexual wellness and routine screening protocols. Significant trends anticipated during this period encompass a greater uptake of discreet self-collection STI screening kits for private, home-based testing; an increasing need for rapid-turnaround sexually transmitted infection diagnostic solutions; a growing inclination among younger adults towards mail-in laboratory sexual health testing services; the broader availability of multi-infection at-home sexual wellness testing panels; and the continuous growth of online pharmacy and direct-to-consumer channels for sexual health testing.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample_request?id=43345945&type=smp

At-Home Sexually Transmitted Infection (STI) Testing Market Expansion Drivers: What Is Shaping Future Growth?

The increasing understanding of sexual health is projected to accelerate the expansion of the at-home sexually transmitted infection (STI) testing market in the future. This awareness encompasses an individual’s comprehension of STIs, how they are transmitted, strategies for prevention, and the significance of consistent testing for prompt diagnosis and intervention. A greater emphasis on sexual health education is primarily fueled by widespread public health initiatives and the removal of stigma associated with STI testing, prompting more people to actively look for information and available testing solutions. The heightened awareness regarding sexual health subsequently fuels the demand for at-home STI testing, as it encourages individuals to pursue discreet, user-friendly, and readily available testing alternatives beyond conventional medical environments. An illustrative example is seen in December 2025, where the UK Health Security Agency, a government entity in the UK, reported an increase of 1.7% in infectious syphilis diagnoses, climbing from 9,375 cases in 2023 to 9,535 cases in 2024. Consequently, the expanding recognition of sexual health is a key factor propelling the expansion of the at-home sexually transmitted infection (STI) testing market.

At-Home Sexually Transmitted Infection (STI) Testing Market Segments: Where Are The Largest Growth Opportunities?

The at-home sexually transmitted infection (sti) testing market covered in this report is segmented –

1) By Type: Rapid Lateral Flow Immunoassays, Molecular Or Nucleic Acid Amplification Technology (NAAT)-Based Kits, Multiplex Panel Testing, Other Types

2) By Infection: Human Immunodeficiency Virus (HIV), Chlamydia Trachomatis (CT), Neisseria Gonorrhoeae (NG), Syphilis, Trichomoniasis, Human Papillomavirus (HPV), Hepatitis B And C, Other Infections

3) By Sample: Blood Samples, Urine Samples, Swab Samples

4) By Distribution: Online Pharmacies And D2C Platforms, Retail Pharmacies, Public Health Distribution Programs, Other Distributions

5) By End User: Individual Consumers, Healthcare Providers, Public Health Programs

Subsegments:

1) By Rapid Lateral Flow Immunoassays: Of Human Immunodeficiency Virus Antibody Detection, Of Syphilis Antibody Detection, Of Chlamydia Antigen Detection, Of Gonorrhea Antigen Detection, Of Hepatitis B Surface Antigen Detection

2) By Molecular Or Nucleic Acid Amplification Technology (NAAT) Based Kits: Of Human Immunodeficiency Virus Nucleic Acid Detection, Of Chlamydia Trachomatis Nucleic Acid Detection, Of Neisseria Gonorrhoeae Nucleic Acid Detection, Of Trichomonas Vaginalis Nucleic Acid Detection, Of Mycoplasma Genitalium Nucleic Acid Detection

3) By Multiplex Panel Testing: Of Combined Human Immunodeficiency Virus And Syphilis Detection, Of Combined Chlamydia And Gonorrhea Detection, Of Comprehensive Bacterial Sexually Transmitted Infection Panel, Of Comprehensive Viral Sexually Transmitted Infection Panel, Of Multi Pathogen Sexual Health Screening Panel

4) By Other Types: Self-Collection Sample Kits, Mail-In Laboratory Testing Kits, Digital Or Connected At-Home Testing Kits, Microfluidic Lab-On-Chip Testing Kits

At-Home Sexually Transmitted Infection (STI) Testing Market Strategic Trends: What Is Defining The Next Phase Of Growth?

Leading firms within the at-home STI testing sector are prioritizing the creation of sophisticated diagnostic methods, specifically instrument-free polymerase chain reaction platforms, to boost detection precision, shorten processing periods, and broaden the availability of professional-grade test outcomes in a home setting. These instrument-free PCR platforms are self-contained molecular diagnostic tools, allowing individuals to collect samples remotely and receive highly accurate pathogen detection results without needing conventional lab apparatus, all while incorporating digital interfaces for safe result transmission and remote healthcare assistance. An example is Visby Medical, a US-based medical diagnostics firm, which introduced its FDA-authorized at-home PCR test for sexually transmitted infections in November 2025. This test identifies chlamydia, gonorrhea, and trichomoniasis, provides results in about 30 minutes, functions as a single-use instrument-free device, and connects with digital platforms for secure result communication and virtual follow-up care. Its design aims to facilitate direct consumer access, elevate molecular accuracy, enhance testing convenience, and allow for effortless treatment guidance through telehealth.

At-Home Sexually Transmitted Infection (STI) Testing Market Major Participants And Competitive Dynamics

Major companies operating in the at-home sexually transmitted infection (sti) testing market are Becton Dickinson and Company (BD), Laboratory Corporation of America Holdings, Randox Laboratories Ltd, LetsGetChecked, Everly Health Inc, myLAB Box LLC, Preventx Ltd, MySTDTestKits, RapidTest. co. uk Ltd, Got Lucky Labs Inc, Biopanda Reagents Ltd, Rapid Labs Ltd, Walk-In Lab LLC, Any Lab Test Now Inc, 4U Health Ltd, Quest Diagnostics Incorporated, ACON Biotech (Hangzhou) Co. Ltd, UroSure Inc, Yoxly Ltd, Genedia Co. Ltd

Access The Complete At-Home Sexually Transmitted Infection (STI) Testing Market Report:

https://www.thebusinessresearchcompany.com/report/at-home-sexually-transmitted-infection-sti-testing-market-report

At-Home Sexually Transmitted Infection (STI) Testing Market Geographic Analysis: Where Is Demand Growing The Fastest?

North America was the largest region in the at-home sexually transmitted infection (STI) testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the at-home sexually transmitted infection (STI) testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model